Iran >>  Iran >> اخبار ویژه
Publish Date : 02 December 2019 - 22:35  ,  
News ID: 6481
TEHRAN(Basirat): Head of Iran's Food and Drug Administration (IFDA) and Deputy Health Minister Mohammadreza Shanehsaz said that Washington's sanctions and the recent warning issued by the US Treasury Department was meant to be a coup against the Iranian patients, particularly those with special needs.
 
Official: US Sanctions Targeting Iranian Patients

"They have declared in the letter that they will provide a special line to supply drugs and medical equipment but they use policing methods to threaten the pharmaceutical companies that in case of providing Iran with medicine and medical equipment, they will not be allowed to export to the EU and the US," Shanehsaz told FNA on Monday.

He added that the US measures have created problems for Iran in supplying drugs to the special patients.

Shanehsaz, meantime, said that the Iranian research centers and knowledge-based companies are producing 97% of needed drugs indigenously.

Iran has taken long strides in producing different types of drugs and medical equipment and exported them to many foreign states.

A recent report by the scientific and technological department of Iran's presidential office said that the country is able to produce 97% of its needs to drugs indigenously.

in July, Iranian Vice-President for Science and Technology Sorena Sattari unveiled 8 new drugs during his visit to knowledge-based companies in Alborz province near Tehran.

The newly-developed drugs included Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo gliatzone and other medicine.

The drugs have applications in treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.

Source:FarsNEWS

Comments
Name:
Email:
* Comment:
* captcha:
Enter the The letters that you see in the picture exactly in the opposite field
Latest News
Most Visited
Send Newsletter
To subscribe to our newsletter enter your email.